Drug development in Alzheimer’s disease: the path to 2025

The global impact of Alzheimer’s disease (AD) continues to increase, and focused efforts are needed to address this immense public health challenge. National leaders have set a goal to prevent or effectively treat AD by 2025. In this paper, we discuss the path to 2025, and what is feasible in this t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Res Ther
Main Authors: Cummings, Jeffrey, Aisen, Paul S., DuBois, Bruno, Frölich, Lutz, Jack, Clifford R., Jones, Roy W., Morris, John C., Raskin, Joel, Dowsett, Sherie A., Scheltens, Philip
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5028936/
https://ncbi.nlm.nih.gov/pubmed/27646601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-016-0207-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados